Case
Arizona Federal Court Determines Novartis Warnings Adequate and Grants Summary Judgment
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | July 2, 2013The U.S. District Court for the District of Arizona granted Novartis Pharmaceuticals Corporation’s (“NPC”) motion for summary judgment based on adequacy of warnings and lack of proximate (or “warnings”) causation in D’Agnese v. Novartis Pharm. Corp.,952…
Novartis Scores Unanimous Defense Verdict from Florida Jury
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | April 9, 2013After deliberating for fewer than forty-five minutes, a federal jury in Tampa, Florida returned a unanimous verdict in favor of Novartis Pharmaceuticals Corporation in a 3-week trial involving Aredia and Zometa, bisphosphonate medicines used to treat…
Davidson v. Velsicol Chem. Corp., 834 P.2d 931 (Nev. 1992)
Case | Products Liability & Toxic Torts | August 12, 1992Southern District of Florida Upholds Removal of a “Pure Bill of Discovery” in Novartis Elidel Case
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | November 26, 2006In 2006, plaintiffs in southern Florida filed a “pure bill of discovery” against Firm client Novartis Pharmaceuticals Corporation. A pure bill of discovery is a little-used Florida procedure, with parallels in a handful of other states,…
Brumbaugh v. Sandoz Pharm. Corp., 77 F. Supp. 2d 1153 (D. Mont. 1999)
Case | Pharmaceutical & Medical Device | September 27, 1999Plaintiff Dismisses Case After Two and a Half Days of Trial
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | September 21, 2012After two and a half days of trial, the plaintiff in Brown v. Novartis Pharm. Corp., No. 7:08-CV-00130-FL (E.D.N.C.), agreed to dismiss with prejudice his claims against Firm client Novartis Pharmaceuticals Corporation (“NPC”). The plaintiff is…
North Carolina Federal Magistrate Says New Jersey Law Should Govern Punitive Damages in Pharmaceutical Case
Case | Pharmaceutical & Medical Device | December 16, 2011A Magistrate Judge in the U.S. District Court for the Eastern District of North Carolina recommended that the motion of Novartis Pharmaceuticals Corporation (“NPC”) to apply New Jersey law to the issue of punitive damages be…
Novartis Bellwether Defense Verdict Upheld on Appeal in New Jersey
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | June 13, 2012The New Jersey Appellate Division affirmed judgment in favor of Novartis Pharmaceuticals Corporation, rejecting plaintiffs’ appeal of a 2010 defense verdict in the first bellwether trial arising out of the Aredia/Zometa consolidated litigation in New Jersey…